TotalMarketCap

Alkermes

ALKSNasdaq IrelandHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$7.500 B

$44.63 -2.75%

Close of 6 Nov 2026

As of 6 Nov 2026, Alkermes (ALKS) has a market capitalization of $7.50B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$1.48B

#1296 by revenue

Earnings

$241.7M

#914 by earnings

Shares outstanding

168,043,540

Latest filing cover page

P/E ratio

31.0

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #38Corcept TherapeuticsCORT$7.86B
  2. #39CytokineticsCYTK$7.74B
  3. #40AlkermesALKS$7.50B
  4. #41AbivaxABVX$7.35B
  5. #42Praxis Precision MedicinesPRAX$7.34B

What if Alkermes were worth as much as…

Open the what-if tool →

Gold $28.2T

$168,033.08

Per share 3,765× higher

Bitcoin $1.53T

$9,091.98

Per share 204× higher

Apple $5.02T

$29,848.11

Per share 669× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Alkermes are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.